Purple Biotech Ltd. (PPBT) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Purple Biotech Ltd. (PPBT) Bundle
Discover the true potential of Purple Biotech Ltd. (PPBT) with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and examine how changes affect the valuation of Purple Biotech Ltd. (PPBT) – all within a single Excel template.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.0 | 1.0 | -.3 | -.9 | .0 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | 0 | -132 | 184.38 | -100 | -25 | -25 | -25 | -25 | -25 |
EBITDA | -6.1 | -28.4 | -17.5 | -21.5 | -22.2 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | -613.7 | -2841 | 5473.75 | 2361.76 | 100 | 20 | 20 | 20 | 20 | 20 |
Depreciation | .2 | .2 | .2 | .2 | .2 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 17.8 | 23.5 | -72.19 | -22.09 | 100 | 9.4 | 9.4 | 9.4 | 9.4 | 9.4 |
EBIT | -6.3 | -28.6 | -17.7 | -21.7 | -22.4 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | -631.5 | -2864.5 | 5545.94 | 2383.85 | 100 | 20 | 20 | 20 | 20 | 20 |
Total Cash | 6.4 | 57.8 | 47.2 | 32.1 | 15.4 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 1.5 | .5 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 149.3 | 50 | 0 | 0 | 100 | 50 | 50 | 50 | 50 | 50 |
Inventories | -1.5 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | -149.3 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1.2 | 1.2 | 1.5 | 2.1 | 3.5 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 124.5 | 119.8 | -460.31 | -234.29 | 100 | 20 | 20 | 20 | 20 | 20 |
Capital Expenditure | .0 | -.2 | -.1 | -.2 | .0 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | -1.1 | -15.6 | 35.94 | 25.05 | 100 | -3.34 | -3.34 | -3.34 | -3.34 | -3.34 |
Tax Rate, % | 0.48556 | 0.48556 | 0.48556 | 0.48556 | 0.48556 | 0.48556 | 0.48556 | 0.48556 | 0.48556 | 0.48556 |
EBITAT | -6.5 | -12.7 | -18.4 | -20.8 | -22.3 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -5.1 | -13.1 | -17.5 | -20.1 | -20.7 | -3.5 | .0 | .0 | .0 | .0 |
WACC, % | 6.49 | 6.36 | 6.49 | 6.48 | 6.49 | 6.46 | 6.46 | 6.46 | 6.46 | 6.46 |
PV UFCF | ||||||||||
SUM PV UFCF | -3.3 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | -3 | |||||||||
Net Debt | -14 | |||||||||
Equity Value | 11 | |||||||||
Diluted Shares Outstanding, MM | 221 | |||||||||
Equity Value Per Share | 0.05 |
What You Will Get
- Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Purple Biotech Ltd. (PPBT) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A sleek Excel model tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive Financial Data: Access reliable pre-loaded historical performance and future forecasts for Purple Biotech Ltd. (PPBT).
- Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries to effectively visualize your valuation insights.
- Designed for All Users: A straightforward, intuitive layout suitable for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Purple Biotech Ltd. (PPBT) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Purple Biotech Ltd.'s (PPBT) intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose Purple Biotech Ltd. (PPBT) Calculator?
- Accuracy: Utilizes real Purple Biotech financial data to ensure precision.
- Flexibility: Built for users to easily adjust and test various inputs.
- Time-Saving: Avoid the complexities of creating a financial model from the ground up.
- Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users with varying financial backgrounds.
Who Should Use Purple Biotech Ltd. (PPBT)?
- Healthcare Investors: Develop comprehensive and accurate valuation models for assessing biotech investments.
- Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within the biotech sector.
- Consultants and Advisors: Deliver precise valuation analyses for clients interested in Purple Biotech Ltd. (PPBT).
- Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling related to biotech.
- Biotech Enthusiasts: Gain insights into how companies like Purple Biotech Ltd. (PPBT) are valued in the investment landscape.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Purple Biotech Ltd. (PPBT) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Purple Biotech Ltd. (PPBT).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.